Journal Logo

December 2019 - Volume 3 - Issue 6
pp: e299-e307

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas, Panagiotis; Tesi, Bianca; Wartiovaara-Kautto, Ulla; More

HemaSphere. 3(6):e321, December 2019.

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

Terpos, Evangelos; Kostopoulos, Ioannis V.; Kastritis, Efstathios; More

HemaSphere. 3(6):e300, December 2019.

Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study

Cattaneo, Chiara; Busca, Alessandro; Gramegna, Doriana; More

HemaSphere. 3(6):e320, December 2019.

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group

Blais, S.; Boutroux, H.; Pasquet, M.; More

HemaSphere. 3(6):e316, December 2019.

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

Anargyrou, Konstantinos; Fotiou, Despina; Vassilakopoulos, Theodoros P.; More

HemaSphere. 3(6):e303, December 2019.

Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling

Hofland, Tom; Endstra, Sanne; Gomes, Calum K.P.; More

HemaSphere. 3(6):e308, December 2019.

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)

Tisi, Maria Chiara; Ferrero, Simone; Dogliotti, Irene; More

HemaSphere. 3(6):e305, December 2019.